City of Hope and Imugene dose patient in Phase 1 trial to test cancer-killing oncolytic virus
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
In clinical trials, treatment proved more effective than other therapies evaluated
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA
In the trial, there was no statistical difference in estimated hypoglycaemia rates, and no severe hypoglycaemia events were observed for people treated with insulin icodec
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
Subscribe To Our Newsletter & Stay Updated